Status:
COMPLETED
Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis, Utilisation of Health Care Resources in Patients With COPD
Lead Sponsor:
Philipps University Marburg
Collaborating Sponsors:
Hannover Medical School
Ludwig-Maximilians - University of Munich
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
40+ years
Brief Summary
The purpose of this study is to determine the prevalence and severity of extrapulmonary disorders and to quantify the impact of extrapulmonary organ manifestations on morbidity and mortality of COPD p...
Detailed Description
Chronic diseases and comorbidities have an increasing impact on individual life and health care use, as exemplified in chronic obstructive pulmonary disease (COPD). Currently, independent, comprehensi...
Eligibility Criteria
Inclusion
- aged 40 years and older
- diagnosis of COPD (GOLD-Criteria) or chronic bronchitis
- informed consent
- available for repeated study visits pver 18 months
Exclusion
- having undergone big lung surgery (e.g. lung reduction, lung transplant)
- Moderate or severe exacerbation within the last 4 weeks
- having a lung tumor
- Unable to walk or to understand the intention of the project
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
2741 Patients enrolled
Trial Details
Trial ID
NCT01245933
Start Date
November 1 2010
End Date
December 1 2023
Last Update
April 12 2024
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Ev. Lungenklinik (ELK), Krankenhausbetriebs gGmbH, Pneumologische Klinik
Berlin, Germany, 13125
2
Forschungszentrum Borstel, Medizinische Klinik
Borstel, Germany, 23845
3
Klinik Donaustauf, Zentrum für Pneumologie
Donaustauf, Germany, 93093
4
Ruhrlandklinik Essen, Westdeutsches Lungenzentrum
Essen, Germany, 45239